Overview

Ketamine Patient-Controlled Analgesia for Acute Pain

Status:
Terminated
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
This study will compare ketamine and hydromorphone as alternative patient-controlled interventions for trauma-related pain. Patients receiving ketamine PCA are expected to require less total and breakthrough opioid and to have similar or improved objective pain scores. Patients receiving ketamine are also expected to have shorter duration of supplemental oxygen requirement, fewer episodes of oxygen desaturation, improved pulmonary toilet, lower use of antiemetics, and shorter times to first bowel movement. Ketamine is further expected to be associated with decreased intensive care unit and hospital lengths of stay, faster time to maximum allowable ambulation, decreased opioid dosage at discharge, and lower report of chronic pain syndromes.
Phase:
Phase 3
Details
Lead Sponsor:
University of Cincinnati
Treatments:
Hydromorphone
Ketamine